The interleukin-8 pathway in cancer.
David J J Waugh1, Catherine Wilson
1Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland. d.waugh@qub.ac.uk
Summary
Interleukin-8 (IL-8) is a key driver of tumor growth and metastasis by promoting angiogenesis and cell proliferation. Targeting IL-8 signaling offers a promising therapeutic strategy for various cancers.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Interleukin-8 (IL-8) is a pro-inflammatory chemokine involved in neutrophil recruitment and activation.
- IL-8 exerts its functions through G protein-coupled receptors CXCR1 and CXCR2.
- Elevated IL-8 levels are observed in the tumor microenvironment, implicating it in cancer progression.
Purpose of the Study:
- To elucidate the multifaceted roles of IL-8 signaling in cancer.
- To explore the impact of IL-8 on tumor angiogenesis, proliferation, survival, and metastasis.
- To investigate IL-8's role in therapeutic resistance and androgen receptor activity.
Main Methods:
- Review of existing literature on IL-8 signaling in cancer.
- Analysis of IL-8's downstream effects on gene expression, translation, and cytoskeleton.
- Examination of IL-8's correlation with tumor characteristics in preclinical models.
Main Results:
- IL-8 signaling promotes angiogenesis, cancer cell proliferation, and survival.
- IL-8 enhances the migration of cancer cells and neutrophils within the tumor.
- IL-8 expression correlates with tumor angiogenesis, tumorigenicity, and metastasis.
- IL-8 influences androgen receptor activity and confers chemotherapeutic resistance.
Conclusions:
- IL-8 is a significant regulatory factor in the tumor microenvironment, driving key oncogenic processes.
- Inhibiting IL-8 signaling presents a potential therapeutic avenue for cancer treatment.
- Targeting IL-8 may overcome therapeutic resistance and improve patient outcomes.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...